Sign up FAST! Login

Ebola 'Secret Serum': Small Biopharma, The Army, And Big Tobacco

Ebola 'Secret Serum': Small Biopharma, The Army, And Big Tobacco - Forbes

The three-antibody mixture originated with Mapp Biopharmaceuticals, a small San Diego-based company established in 2003 and led by Larry Zeitlin, Ph.D., a Johns Hopkins-trained reproductive biologist who became an expert in “plantibodies,” antibody therapeutics produced in, and purified from, bioengineered plants.

The ZMapp three-antibody cocktail isn’t a vaccine. Instead, it provides an artifical immune response against sugar-tagged proteins on the outside of the Ebolavirus.

These three antibodies represent a clever strategy against the virus. One of the antibodies binds up a form of Ebolavirus protein that seems to be sent off by the virus as a decoy against the immune response.

Stashed in: Medicine, Medical Money to be made, Biotech!, Ebola!

To save this post, select a stash from drop-down menu or type in a new one:

I love the word "plantibodies" -- this is an area that has a lot of potential in the future.

You May Also Like: